Total Payments
$889.65
2023 Payments
$49.31
Companies
17
Transactions
34
Medicare Patients
5,505
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$864.20 (97.1%)
Education$25.45 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $864.20 | 32 | 97.1% |
| Education | $25.45 | 2 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $184.84 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $129.63 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $123.27 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $101.92 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $63.22 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $49.45 | 3 | $0 (2020) |
| ABIOMED | $45.11 | 1 | $0 (2018) |
| Theravance Biopharma Inc. | $37.22 | 2 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $21.73 | 1 | $0 (2019) |
| AbbVie Inc. | $19.62 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $49.31 | 3 | CVRx, Inc. ($19.24) |
| 2022 | $209.11 | 2 | JAZZ PHARMACEUTICALS INC. ($123.26) |
| 2021 | $56.95 | 3 | JAZZ PHARMACEUTICALS INC. ($21.46) |
| 2020 | $30.93 | 2 | GlaxoSmithKline, LLC. ($19.37) |
| 2019 | $154.98 | 9 | E.R. Squibb & Sons, L.L.C. ($52.66) |
| 2018 | $197.96 | 9 | E.R. Squibb & Sons, L.L.C. ($56.91) |
| 2017 | $190.41 | 6 | Novartis Pharmaceuticals Corporation ($101.92) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 05/02/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Heart Failure and Hypertension | ||||||
| 01/27/2023 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 08/20/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $123.26 | General |
| Category: NEUROLOGY | ||||||
| 05/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $85.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/30/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: NEUROLOGY | ||||||
| 04/27/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/12/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/26/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 02/17/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Cardiovascular | ||||||
| 09/09/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: Cardiovascular | ||||||
| 06/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.70 | General |
| Category: Cardiovascular | ||||||
| 05/28/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: NEPHROLOGY | ||||||
| 03/05/2019 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Immunology | ||||||
| 02/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Cardiovascular | ||||||
| 10/11/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Cardiovascular | ||||||
| 09/27/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Cardiovascular | ||||||
| 09/13/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: VACCINES | ||||||
| 09/06/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), ADACEL | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: VACCINES | ||||||
| 04/19/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $40.12 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,350 | 2,635 | $670,569 | $239,635 |
| 2022 | 13 | 1,071 | 2,310 | $518,856 | $210,041 |
| 2021 | 13 | 1,190 | 2,873 | $611,339 | $282,252 |
| 2020 | 19 | 1,894 | 4,321 | $780,545 | $395,733 |
Total Patients
5,505
Total Services
12,139
Medicare Billing
$1.1M
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 132 | 440 | $242,880 | $72,364 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 287 | 1,105 | $157,735 | $68,883 | 43.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 235 | 294 | $116,368 | $40,185 | 34.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 179 | 227 | $47,780 | $20,458 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 99 | $25,433 | $9,313 | 36.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 69 | $14,182 | $6,404 | 45.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 59 | $15,972 | $5,886 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 54 | $9,887 | $3,652 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $6,767 | $3,269 | 48.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 21 | 28 | $6,944 | $2,308 | 33.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 20 | 20 | $4,704 | $1,840 | 39.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 13 | 13 | $3,822 | $1,377 | 36.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 16 | 17 | $7,106 | $1,151 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 13 | $2,361 | $677.69 | 28.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 15 | 15 | $2,186 | $570.45 | 26.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 45 | 45 | $1,842 | $418.05 | 22.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 48 | 48 | $1,610 | $383.04 | 23.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 48 | 48 | $1,912 | $332.64 | 17.4% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 12 | 15 | $1,080 | $161.14 | 14.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 139 | 439 | $242,328 | $76,610 | 31.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 286 | 1,152 | $123,684 | $64,661 | 52.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 134 | 157 | $57,852 | $24,623 | 42.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 124 | 141 | $26,129 | $11,586 | 44.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 119 | 126 | $14,676 | $10,221 | 69.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 120 | 129 | $9,305 | $7,358 | 79.1% |
About Dr. Aluino Ochoa, M.D
Dr. Aluino Ochoa, M.D is a Specialist healthcare provider based in Titusville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215939509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aluino Ochoa, M.D has received a total of $889.65 in payments from pharmaceutical and medical device companies, with $49.31 received in 2023. These payments were reported across 34 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($864.20).
As a Medicare-enrolled provider, Ochoa has provided services to 5,505 Medicare beneficiaries, totaling 12,139 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Critical Care Medicine, Internal Medicine
- Location Titusville, FL
- Active Since 06/01/2005
- Last Updated 01/11/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1215939509
Products in Payments
- ELIQUIS (Drug) $148.61
- XARELTO (Drug) $123.27
- XYWAV (Drug) $123.26
- ENTRESTO (Drug) $101.92
- Impella (Device) $45.11
- Xyrem (Drug) $40.12
- LOKELMA (Drug) $37.89
- VIBATIV (Drug) $37.22
- SHINGRIX (Biological) $30.99
- JYNARQUE (Drug) $21.73
- SUNOSI (Drug) $21.46
- CREON (Drug) $19.62
- TRELEGY ELLIPTA (Drug) $19.37
- Barostim Neo System (Device) $19.24
- Xolair (Biological) $17.49
- Rybelsus (Drug) $16.18
- ZENPEP (Drug) $15.87
- ANORO (Drug) $12.86
- FLUZONE HIGH-DOSE (Drug) $11.99
- BREZTRI AEROSPHERE (Drug) $11.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Titusville
Dr. Robert Mcshane, M.d, M.D
Specialist — Payments: $4,872
Specialist $4,872
Dr. Sachin Shenoy, Md, MD
Specialist — Payments: $2,259
Specialist $2,259
Dr. Justo Gonzalez, M.d, M.D
Specialist — Payments: $1,665
Specialist $1,665
Dr. Imran Rashid, M.d, M.D
Specialist — Payments: $1,573
Specialist $1,573
Dr. Joseph Rojas, M.d, M.D
Specialist — Payments: $1,120
Specialist $1,120
Dr. Karin Ochoa, Md, MD
Specialist — Payments: $593.60
Specialist $593.60